Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Arch Pharm (Weinheim) Année : 2017

Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni

Katharina Stenzel
  • Fonction : Auteur
Alokta Chakrabarti
  • Fonction : Auteur
Jelena Melesina
  • Fonction : Auteur
Finn Hansen
  • Fonction : Auteur
Julien Lancelot
Simon Herkenhohner
  • Fonction : Auteur
Beate Lungerich
  • Fonction : Auteur
Raymond Pierce
Wolfgang Sippl
Manfred Jung
  • Fonction : Auteur
T Kurz
  • Fonction : Auteur

Résumé

Schistosoma mansoni histone deacetylase 8 (SmHDAC8) has been recently identified as a new potential target for the treatment of schistosomiasis. A series of newly designed and synthesized alkoxyamide-based and hydrazide-based HDAC inhibitors were tested for inhibitory activity against SmHDAC8 and human HDACs 1, 6, and 8. The front runner compounds showed submicromolar activity against SmHDAC8 and modest preference for SmHDAC8 over its human orthologue hHDAC8. Docking studies provided insights into the putative binding mode in SmHDAC8 and allowed rationalization of the observed selectivity profile.
Fichier non déposé

Dates et versions

hal-03691172 , version 1 (08-06-2022)

Identifiants

Citer

Katharina Stenzel, Alokta Chakrabarti, Jelena Melesina, Finn Hansen, Julien Lancelot, et al.. Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni. Arch Pharm (Weinheim), 2017, 350 (8), ⟨10.1002/ardp.201700096⟩. ⟨hal-03691172⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More